Article Details
Retrieved on: 2024-02-05 20:13:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Arca Biopharma told investors that its cash and cash equivalents “will be sufficient to fund its operations through the middle of 2025.”
Article found on: bizwest.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here